Dubbing language-therapy CINEma-based in aphasia post-stroke (DULCINEA): A feasibility randomized crossover controlled trial
Helping people recover from aphasia is among the top 10 research priorities relating to life after stroke. We aimed to evaluate the feasibility of dubbing techniques (using newly developed software) for post-stroke aphasia therapy and explore its potential efficacy. Randomised, crossover, interventi...
Saved in:
Published in | Digital health Vol. 10; p. 20552076241288311 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
SAGE Publications
01.01.2024
SAGE Publishing |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Helping people recover from aphasia is among the top 10 research priorities relating to life after stroke.
We aimed to evaluate the feasibility of dubbing techniques (using newly developed software) for post-stroke aphasia therapy and explore its potential efficacy.
Randomised, crossover, interventional, feasibility trial that included patients with chronic post-stroke non-fluent aphasia. The intervention consisted of an individualised programme (16 sessions; 8 weeks) based on dubbing words and sentences progressively adapted to the severity of the aphasia. Patients were allocated to groups that underwent therapy within the first 3 months, or between 3 and 6 months from inclusion, each group serving as the control during the non-therapy periods. Outcomes were the pre-post differences in the Communicative Activity Log, the Boston Diagnostic Aphasia Examination, the General Health Questionnaire-12, the Stroke Aphasia Quality of Life Scale, and the Western Aphasia Battery Revised, administered by psychologists blinded to the patients' allocation.
Recruitment was limited due to COVID-19 and prematurely stopped because of funding coming to an end. A total of 23 patients were randomised, 20 of whom completed the study (1 withdrew consent, and 2 dropped out). The adherence rate to the allocated group was 95.3%. No statistically significant differences were found in any of the outcomes; however, 17 (85%) patients reported subjective improvements in communication skills.
This trial shows the feasibility of dubbing therapy (using dedicated software) for patients with post-stroke non-fluent aphasia. Although it lacks statistical power, certain effects on language and communication cannot be ignored. |
---|---|
AbstractList | Background Helping people recover from aphasia is among the top 10 research priorities relating to life after stroke. Objective We aimed to evaluate the feasibility of dubbing techniques (using newly developed software) for post-stroke aphasia therapy and explore its potential efficacy. Methods Randomised, crossover, interventional, feasibility trial that included patients with chronic post-stroke non-fluent aphasia. The intervention consisted of an individualised programme (16 sessions; 8 weeks) based on dubbing words and sentences progressively adapted to the severity of the aphasia. Patients were allocated to groups that underwent therapy within the first 3 months, or between 3 and 6 months from inclusion, each group serving as the control during the non-therapy periods. Outcomes were the pre-post differences in the Communicative Activity Log, the Boston Diagnostic Aphasia Examination, the General Health Questionnaire-12, the Stroke Aphasia Quality of Life Scale, and the Western Aphasia Battery Revised, administered by psychologists blinded to the patients’ allocation. Results Recruitment was limited due to COVID-19 and prematurely stopped because of funding coming to an end. A total of 23 patients were randomised, 20 of whom completed the study (1 withdrew consent, and 2 dropped out). The adherence rate to the allocated group was 95.3%. No statistically significant differences were found in any of the outcomes; however, 17 (85%) patients reported subjective improvements in communication skills. Conclusions This trial shows the feasibility of dubbing therapy (using dedicated software) for patients with post-stroke non-fluent aphasia. Although it lacks statistical power, certain effects on language and communication cannot be ignored. Helping people recover from aphasia is among the top 10 research priorities relating to life after stroke. We aimed to evaluate the feasibility of dubbing techniques (using newly developed software) for post-stroke aphasia therapy and explore its potential efficacy. Randomised, crossover, interventional, feasibility trial that included patients with chronic post-stroke non-fluent aphasia. The intervention consisted of an individualised programme (16 sessions; 8 weeks) based on dubbing words and sentences progressively adapted to the severity of the aphasia. Patients were allocated to groups that underwent therapy within the first 3 months, or between 3 and 6 months from inclusion, each group serving as the control during the non-therapy periods. Outcomes were the pre-post differences in the Communicative Activity Log, the Boston Diagnostic Aphasia Examination, the General Health Questionnaire-12, the Stroke Aphasia Quality of Life Scale, and the Western Aphasia Battery Revised, administered by psychologists blinded to the patients' allocation. Recruitment was limited due to COVID-19 and prematurely stopped because of funding coming to an end. A total of 23 patients were randomised, 20 of whom completed the study (1 withdrew consent, and 2 dropped out). The adherence rate to the allocated group was 95.3%. No statistically significant differences were found in any of the outcomes; however, 17 (85%) patients reported subjective improvements in communication skills. This trial shows the feasibility of dubbing therapy (using dedicated software) for patients with post-stroke non-fluent aphasia. Although it lacks statistical power, certain effects on language and communication cannot be ignored. Helping people recover from aphasia is among the top 10 research priorities relating to life after stroke.BackgroundHelping people recover from aphasia is among the top 10 research priorities relating to life after stroke.We aimed to evaluate the feasibility of dubbing techniques (using newly developed software) for post-stroke aphasia therapy and explore its potential efficacy.ObjectiveWe aimed to evaluate the feasibility of dubbing techniques (using newly developed software) for post-stroke aphasia therapy and explore its potential efficacy.Randomised, crossover, interventional, feasibility trial that included patients with chronic post-stroke non-fluent aphasia. The intervention consisted of an individualised programme (16 sessions; 8 weeks) based on dubbing words and sentences progressively adapted to the severity of the aphasia. Patients were allocated to groups that underwent therapy within the first 3 months, or between 3 and 6 months from inclusion, each group serving as the control during the non-therapy periods. Outcomes were the pre-post differences in the Communicative Activity Log, the Boston Diagnostic Aphasia Examination, the General Health Questionnaire-12, the Stroke Aphasia Quality of Life Scale, and the Western Aphasia Battery Revised, administered by psychologists blinded to the patients' allocation.MethodsRandomised, crossover, interventional, feasibility trial that included patients with chronic post-stroke non-fluent aphasia. The intervention consisted of an individualised programme (16 sessions; 8 weeks) based on dubbing words and sentences progressively adapted to the severity of the aphasia. Patients were allocated to groups that underwent therapy within the first 3 months, or between 3 and 6 months from inclusion, each group serving as the control during the non-therapy periods. Outcomes were the pre-post differences in the Communicative Activity Log, the Boston Diagnostic Aphasia Examination, the General Health Questionnaire-12, the Stroke Aphasia Quality of Life Scale, and the Western Aphasia Battery Revised, administered by psychologists blinded to the patients' allocation.Recruitment was limited due to COVID-19 and prematurely stopped because of funding coming to an end. A total of 23 patients were randomised, 20 of whom completed the study (1 withdrew consent, and 2 dropped out). The adherence rate to the allocated group was 95.3%. No statistically significant differences were found in any of the outcomes; however, 17 (85%) patients reported subjective improvements in communication skills.ResultsRecruitment was limited due to COVID-19 and prematurely stopped because of funding coming to an end. A total of 23 patients were randomised, 20 of whom completed the study (1 withdrew consent, and 2 dropped out). The adherence rate to the allocated group was 95.3%. No statistically significant differences were found in any of the outcomes; however, 17 (85%) patients reported subjective improvements in communication skills.This trial shows the feasibility of dubbing therapy (using dedicated software) for patients with post-stroke non-fluent aphasia. Although it lacks statistical power, certain effects on language and communication cannot be ignored.ConclusionsThis trial shows the feasibility of dubbing therapy (using dedicated software) for patients with post-stroke non-fluent aphasia. Although it lacks statistical power, certain effects on language and communication cannot be ignored. |
Author | Jordi-Perea, Pablo Ruiz-Ares, Gerardo Rigual, Ricardo Fuentes, Blanca Tarifa-Rodríguez, Aida Borobia, Alberto M Sempere-Iborra, Cristian Alonso-López, Elisa Jiménez-González, María Bueno, Nereida Martín Alonso, Marta Virués-Ortega, Javier de Celis-Ruiz, Elena Alonso de Leciñana, María Blanco, Paloma Martínez-Balaguer, María Rodríguez-Pardo, Jorge |
AuthorAffiliation | 2 Neurosciences Area, IdiPAZ Institute for Health Research, Madrid, Spain 6 Asociación Afasia Activa, Madrid, Spain 5 Clinical Trials Unit. Department of Clinical Pharmacology, 16268 La Paz University Hospital , IdiPAZ Institute for Health Research, Madrid, Spain 1 Department of Neurology and Stroke Centre, La Paz University Hospital, Department of Medicine, Universidad Autónoma de Madrid, Neurosciences Area, IdiPAZ Institute for Health Research, Madrid, Spain 3 Department of Psychology, The University of Auckland, Auckland, New Zealand 4 Speech and Language Unit. Department of Rehabilitation, 16268 La Paz University Hospital , Madrid, Spain 7 Department of Psychology, 16768 Universidad Pontificia Comillas , Madrid, Spain |
AuthorAffiliation_xml | – name: 7 Department of Psychology, 16768 Universidad Pontificia Comillas , Madrid, Spain – name: 1 Department of Neurology and Stroke Centre, La Paz University Hospital, Department of Medicine, Universidad Autónoma de Madrid, Neurosciences Area, IdiPAZ Institute for Health Research, Madrid, Spain – name: 3 Department of Psychology, The University of Auckland, Auckland, New Zealand – name: 4 Speech and Language Unit. Department of Rehabilitation, 16268 La Paz University Hospital , Madrid, Spain – name: 2 Neurosciences Area, IdiPAZ Institute for Health Research, Madrid, Spain – name: 5 Clinical Trials Unit. Department of Clinical Pharmacology, 16268 La Paz University Hospital , IdiPAZ Institute for Health Research, Madrid, Spain – name: 6 Asociación Afasia Activa, Madrid, Spain |
Author_xml | – sequence: 1 givenname: Blanca orcidid: 0000-0002-0363-862X surname: Fuentes fullname: Fuentes, Blanca organization: Department of Neurology and Stroke Centre, La Paz University Hospital, Department of Medicine, Universidad Autónoma de Madrid, Neurosciences Area, IdiPAZ Institute for Health Research, Madrid, Spain – sequence: 2 givenname: Pablo surname: Jordi-Perea fullname: Jordi-Perea, Pablo organization: Neurosciences Area, IdiPAZ Institute for Health Research, Madrid, Spain – sequence: 3 givenname: Cristian surname: Sempere-Iborra fullname: Sempere-Iborra, Cristian organization: Neurosciences Area, IdiPAZ Institute for Health Research, Madrid, Spain – sequence: 4 givenname: Aida surname: Tarifa-Rodríguez fullname: Tarifa-Rodríguez, Aida organization: Department of Psychology, The University of Auckland, Auckland, New Zealand – sequence: 5 givenname: Elena surname: de Celis-Ruiz fullname: de Celis-Ruiz, Elena organization: Department of Neurology and Stroke Centre, La Paz University Hospital, Department of Medicine, Universidad Autónoma de Madrid, Neurosciences Area, IdiPAZ Institute for Health Research, Madrid, Spain – sequence: 6 givenname: Marta surname: Martín Alonso fullname: Martín Alonso, Marta organization: Speech and Language Unit. Department of Rehabilitation, La Paz University Hospital, Madrid, Spain – sequence: 7 givenname: Gerardo surname: Ruiz-Ares fullname: Ruiz-Ares, Gerardo organization: Department of Neurology and Stroke Centre, La Paz University Hospital, Department of Medicine, Universidad Autónoma de Madrid, Neurosciences Area, IdiPAZ Institute for Health Research, Madrid, Spain – sequence: 8 givenname: Ricardo surname: Rigual fullname: Rigual, Ricardo organization: Department of Neurology and Stroke Centre, La Paz University Hospital, Department of Medicine, Universidad Autónoma de Madrid, Neurosciences Area, IdiPAZ Institute for Health Research, Madrid, Spain – sequence: 9 givenname: Jorge surname: Rodríguez-Pardo fullname: Rodríguez-Pardo, Jorge organization: Department of Neurology and Stroke Centre, La Paz University Hospital, Department of Medicine, Universidad Autónoma de Madrid, Neurosciences Area, IdiPAZ Institute for Health Research, Madrid, Spain – sequence: 10 givenname: Elisa surname: Alonso-López fullname: Alonso-López, Elisa organization: Department of Neurology and Stroke Centre, La Paz University Hospital, Department of Medicine, Universidad Autónoma de Madrid, Neurosciences Area, IdiPAZ Institute for Health Research, Madrid, Spain – sequence: 11 givenname: María orcidid: 0000-0002-4302-6580 surname: Alonso de Leciñana fullname: Alonso de Leciñana, María organization: Department of Neurology and Stroke Centre, La Paz University Hospital, Department of Medicine, Universidad Autónoma de Madrid, Neurosciences Area, IdiPAZ Institute for Health Research, Madrid, Spain – sequence: 12 givenname: Javier surname: Virués-Ortega fullname: Virués-Ortega, Javier organization: Department of Psychology, The University of Auckland, Auckland, New Zealand – sequence: 13 givenname: Alberto M surname: Borobia fullname: Borobia, Alberto M organization: Clinical Trials Unit. Department of Clinical Pharmacology, La Paz University Hospital, IdiPAZ Institute for Health Research, Madrid, Spain – sequence: 14 givenname: María surname: Jiménez-González fullname: Jiménez-González, María organization: Clinical Trials Unit. Department of Clinical Pharmacology, La Paz University Hospital, IdiPAZ Institute for Health Research, Madrid, Spain – sequence: 15 givenname: María surname: Martínez-Balaguer fullname: Martínez-Balaguer, María organization: Clinical Trials Unit. Department of Clinical Pharmacology, La Paz University Hospital, IdiPAZ Institute for Health Research, Madrid, Spain – sequence: 16 givenname: Paloma surname: Blanco fullname: Blanco, Paloma organization: Asociación Afasia Activa, Madrid, Spain – sequence: 17 givenname: Nereida surname: Bueno fullname: Bueno, Nereida organization: Department of Psychology, Universidad Pontificia Comillas, Madrid, Spain |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39421311$$D View this record in MEDLINE/PubMed |
BookMark | eNplks1u1DAUhS1UREvpA7BBWbaLFP9lbLNBo2mBkUawoWvr2nEyLkkc7KTSIB4eT6etWrGydXzOd23f-xYdDWFwCL0n-JIQIT5SXFUUiwXlhErJCHmFTvZauRePnu2P0VlKtxhjIphQZPEGHTPFKcmRE_T3ajbGD23RwdDO0Lpy2roI465Yrb9f91AaSK4u_FDAuIXkoRhDmso0xfDLFedXN5u9b3nxqVgWjcsG4zs_7YoIQx16_ydnbQwphTsXCxuGnOu6LE7RQ_cOvW6gS-7sYT1FN1-uf66-lZsfX9er5aa0jMuptAaIMJVZMFxRSTCRtcXGkKZulDUVKFfzWgrVKKpqjsEoC5Y5To2rWCUFO0XrA7cOcKvH6HuIOx3A63shxFZDnLztnLaOWmyxBCMZr4gAJh1rgNYNZVZIyKzPB9Y4m97V1uUnQfcC-vJk8FvdhjtNCJdMUpUJ5w-EGH7PLk2698m6LnfAhTnp3BehlJScZys5WO__MLrmqQ7Bej8F-r8pyJkPzy_4lHjsOfsH_hawMQ |
Cites_doi | 10.1177/17474930211065917 10.1016/j.apmr.2016.03.006 10.1177/1073858413513502 10.3389/fnins.2024.1347614 10.1002/hsr2.1482 10.1177/17474930221097477 10.1080/02687038.2020.1852003 10.3758/BF03193857 10.1177/17474930231161454 10.1177/0269215518791004 10.1177/02692155221131241 10.1037/neu0000396 10.3389/fnhum.2014.00727 10.1044/jshd.2802.191 10.1901/jaba.1989.22-157 10.1093/brain/aws301 10.15252/embr.202154000 10.3389/fnhum.2013.00749 10.1093/applin/aml048 10.1186/1755-7682-6-41 10.1161/STROKEAHA.120.031162 10.1186/s13063-021-05956-5 10.1016/S1474-4422(19)30192-9 10.1080/02687031003798254 10.1007/s00221-023-06743-1 10.3109/09638288.2010.488712 10.1371/journal.pone.0174065 10.1080/02687030701612213 10.3389/fnhum.2014.00246 10.1177/1747493018806200 10.3389/fpsyg.2015.01665 10.1037/0278-7393.16.6.1084 10.1191/026921598672167702 10.7326/0003-4819-152-11-201006010-00232 10.1111/j.1747-4949.2012.00942.x 10.7326/0003-4819-158-3-201302050-00583 |
ContentType | Journal Article |
Copyright | The Author(s) 2024. The Author(s) 2024 2024 SAGE Publications Ltd, unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses |
Copyright_xml | – notice: The Author(s) 2024. – notice: The Author(s) 2024 2024 SAGE Publications Ltd, unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses |
DBID | NPM AAYXX CITATION 7X8 5PM DOA |
DOI | 10.1177/20552076241288311 |
DatabaseName | PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | CrossRef PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2055-2076 |
ExternalDocumentID | oai_doaj_org_article_ce2c0c08ab834517a38e3fa2df23c78a 10_1177_20552076241288311 39421311 |
Genre | Journal Article |
GrantInformation_xml | – fundername: ; grantid: RD21/0006/0012 – fundername: ; grantid: LCF/PR/HR19/52160009 |
GroupedDBID | 0R~ 31X 53G 54M 5VS 7X7 8FI 8FJ AAJPV AAJQC AANEX AATBZ ABAFQ ABAWP ABNCE ABQXT ABUWG ABVFX ABXGC ACARO ACGFS ACGZU ACROE ACSIQ ADBBV ADOGD AEFTW AEUHG AEUIJ AEWDL AEWHI AFCOW AFKRA AFKRG AFRWT AJUZI ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AUTPY AYAKG BAWUL BCNDV BDDNI BDZRT BENPR BMVBW BPHCQ BSEHC BVXVI CCPQU DC. DF. DIK DV7 EBS EJD FYUFA GROUPED_DOAJ GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION H13 HMCUK HYE J8X K.F KQ8 M~E NPM O9- OK1 PIMPY PQQKQ Q7P ROL RPM SFC SFH SFK SFT SGV SPP UKHRP Y4B AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c348t-cba17b5b6305281018dc0bb1fdf9cb5a9ed4d879f929d40ab9cac3e42be535873 |
IEDL.DBID | RPM |
ISSN | 2055-2076 |
IngestDate | Mon Oct 21 19:39:30 EDT 2024 Fri Oct 18 05:24:48 EDT 2024 Sat Oct 19 17:15:51 EDT 2024 Wed Oct 16 15:13:23 EDT 2024 Sat Nov 02 12:04:55 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | feasibility aphasia Stroke < Disease software randomised clinical trial |
Language | English |
License | The Author(s) 2024. This article is distributed under the terms of the Creative Commons Attribution-NoDerivs 4.0 License (https://creativecommons.org/licenses/by-nc-nd/4.0/) which permits any use, reproduction and distribution of the work as published without adaptation or alteration, provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c348t-cba17b5b6305281018dc0bb1fdf9cb5a9ed4d879f929d40ab9cac3e42be535873 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors share principal investigator responsibilities. |
ORCID | 0000-0002-0363-862X 0000-0002-4302-6580 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11483829/ |
PMID | 39421311 |
PQID | 3117998844 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_ce2c0c08ab834517a38e3fa2df23c78a pubmedcentral_primary_oai_pubmedcentral_nih_gov_11483829 proquest_miscellaneous_3117998844 crossref_primary_10_1177_20552076241288311 pubmed_primary_39421311 |
PublicationCentury | 2000 |
PublicationDate | 2024-01-01 |
PublicationDateYYYYMMDD | 2024-01-01 |
PublicationDate_xml | – month: 01 year: 2024 text: 2024-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Sage UK: London, England |
PublicationTitle | Digital health |
PublicationTitleAlternate | Digit Health |
PublicationYear | 2024 |
Publisher | SAGE Publications SAGE Publishing |
Publisher_xml | – name: SAGE Publications – name: SAGE Publishing |
References | Vaezipour A (bibr44-20552076241288311) 2020; 8 bibr39-20552076241288311 bibr13-20552076241288311 bibr23-20552076241288311 bibr16-20552076241288311 R Core Team (bibr29-20552076241288311) 2018 bibr19-20552076241288311 bibr36-20552076241288311 bibr31-20552076241288311 Rocha KB (bibr24-20552076241288311) 2011; 11 bibr41-20552076241288311 bibr18-20552076241288311 bibr21-20552076241288311 bibr11-20552076241288311 bibr15-20552076241288311 bibr5-20552076241288311 Eldridge SM (bibr17-20552076241288311) 2016; 355 bibr2-20552076241288311 bibr12-20552076241288311 Brady MC (bibr35-20552076241288311) 2022; 29 bibr8-20552076241288311 García-Albea J (bibr20-20552076241288311) 1986 bibr45-20552076241288311 bibr28-20552076241288311 bibr38-20552076241288311 bibr42-20552076241288311 Brady MC (bibr7-20552076241288311) 2016; 2016 bibr22-20552076241288311 bibr32-20552076241288311 Sanchez-Lopez M (bibr25-20552076241288311) 2008; 20 bibr1-20552076241288311 bibr27-20552076241288311 bibr4-20552076241288311 bibr37-20552076241288311 bibr14-20552076241288311 bibr34-20552076241288311 bibr40-20552076241288311 bibr43-20552076241288311 bibr9-20552076241288311 bibr6-20552076241288311 bibr33-20552076241288311 bibr3-20552076241288311 Lata-Caneda MC (bibr26-20552076241288311) 2009; 45 bibr30-20552076241288311 bibr10-20552076241288311 |
References_xml | – ident: bibr1-20552076241288311 doi: 10.1177/17474930211065917 – ident: bibr2-20552076241288311 doi: 10.1016/j.apmr.2016.03.006 – ident: bibr13-20552076241288311 doi: 10.1177/1073858413513502 – ident: bibr38-20552076241288311 doi: 10.3389/fnins.2024.1347614 – ident: bibr32-20552076241288311 doi: 10.1002/hsr2.1482 – ident: bibr34-20552076241288311 doi: 10.1177/17474930221097477 – ident: bibr3-20552076241288311 doi: 10.1080/02687038.2020.1852003 – volume: 2016 start-page: 1 year: 2016 ident: bibr7-20552076241288311 publication-title: Cochrane Database Syst Rev contributor: fullname: Brady MC – ident: bibr37-20552076241288311 doi: 10.3758/BF03193857 – ident: bibr6-20552076241288311 doi: 10.1177/17474930231161454 – ident: bibr28-20552076241288311 doi: 10.1177/0269215518791004 – ident: bibr43-20552076241288311 doi: 10.1177/02692155221131241 – volume: 355 start-page: 1 year: 2016 ident: bibr17-20552076241288311 publication-title: BMJ (Online) contributor: fullname: Eldridge SM – ident: bibr41-20552076241288311 doi: 10.1037/neu0000396 – volume-title: A language and environment for statistical computing year: 2018 ident: bibr29-20552076241288311 contributor: fullname: R Core Team – ident: bibr12-20552076241288311 doi: 10.3389/fnhum.2014.00727 – ident: bibr8-20552076241288311 doi: 10.1044/jshd.2802.191 – ident: bibr42-20552076241288311 doi: 10.1901/jaba.1989.22-157 – ident: bibr10-20552076241288311 doi: 10.1093/brain/aws301 – ident: bibr45-20552076241288311 doi: 10.15252/embr.202154000 – ident: bibr11-20552076241288311 doi: 10.3389/fnhum.2013.00749 – ident: bibr16-20552076241288311 doi: 10.1093/applin/aml048 – ident: bibr40-20552076241288311 doi: 10.1186/1755-7682-6-41 – ident: bibr33-20552076241288311 doi: 10.1161/STROKEAHA.120.031162 – volume: 8 year: 2020 ident: bibr44-20552076241288311 publication-title: JMIR Mhealth Uhealth contributor: fullname: Vaezipour A – volume: 29 start-page: 956 year: 2022 ident: bibr35-20552076241288311 publication-title: Stroke contributor: fullname: Brady MC – ident: bibr19-20552076241288311 doi: 10.1186/s13063-021-05956-5 – ident: bibr31-20552076241288311 doi: 10.1016/S1474-4422(19)30192-9 – ident: bibr9-20552076241288311 doi: 10.1080/02687031003798254 – ident: bibr21-20552076241288311 doi: 10.1007/s00221-023-06743-1 – ident: bibr4-20552076241288311 doi: 10.3109/09638288.2010.488712 – volume: 45 start-page: 379 year: 2009 ident: bibr26-20552076241288311 publication-title: Eur J Phys Rehabil Med contributor: fullname: Lata-Caneda MC – volume: 11 start-page: 125 year: 2011 ident: bibr24-20552076241288311 publication-title: Int J Clin Health Psychol contributor: fullname: Rocha KB – ident: bibr36-20552076241288311 doi: 10.1371/journal.pone.0174065 – start-page: 129 volume-title: La evaluación de la afasia y de trastornos relacionados year: 1986 ident: bibr20-20552076241288311 contributor: fullname: García-Albea J – ident: bibr22-20552076241288311 doi: 10.1080/02687030701612213 – ident: bibr14-20552076241288311 doi: 10.3389/fnhum.2014.00246 – ident: bibr23-20552076241288311 doi: 10.1177/1747493018806200 – ident: bibr39-20552076241288311 doi: 10.3389/fpsyg.2015.01665 – ident: bibr15-20552076241288311 doi: 10.1037/0278-7393.16.6.1084 – ident: bibr27-20552076241288311 doi: 10.1191/026921598672167702 – ident: bibr30-20552076241288311 doi: 10.7326/0003-4819-152-11-201006010-00232 – ident: bibr5-20552076241288311 doi: 10.1111/j.1747-4949.2012.00942.x – ident: bibr18-20552076241288311 doi: 10.7326/0003-4819-158-3-201302050-00583 – volume: 20 start-page: 839 year: 2008 ident: bibr25-20552076241288311 publication-title: Psicothema contributor: fullname: Sanchez-Lopez M |
SSID | ssj0001737916 |
Score | 2.2901073 |
Snippet | Helping people recover from aphasia is among the top 10 research priorities relating to life after stroke.
We aimed to evaluate the feasibility of dubbing... Background Helping people recover from aphasia is among the top 10 research priorities relating to life after stroke. Objective We aimed to evaluate the... Helping people recover from aphasia is among the top 10 research priorities relating to life after stroke.BackgroundHelping people recover from aphasia is... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 20552076241288311 |
SubjectTerms | Original |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQHhAXxJvykpE4AFJEbI9rm1vZhxbE7olKe4v8ZCvYpNqmh0X8eMZOumoBiQvXxEkmnrHmm_H4G0JeSc185CFn7q2oIALgmlNQJQPWuAAm6nze-eR0ejyHT2fybKvVV64JG-iBh4l7h2_yta-1dVqAZMoKHUWyPCQuvNIDNKrNVjBVsitKKAQ-4zZmZljitZQcg3b0WLnBLmM7jqjw9f8NZP5eK7nlfI7ukNsjaqSzQdq75EZs75GbJ-O--H3y82DtMMT9Sjfpx2o4V3VF9z-eHl7YKjurQBcttcvzfG6SLrtVX636y-5bpK8P5p_zuNmb93RGU7RjyewVRUcWuovFD3y2_EWu96Rjdft3vFh6fjwg86PDL_vH1dhXofICdF95Z5ly0k1xrfNM8KWDr51jKSTjnbQmBghamYTQKUBtnfHWiwjcRSmkVuIh2Wu7Nj4mFJRK6AZ1mEoLIVonjPcYciedfJwKNiFvN5PcLAf6jIaNDON_aGRCPmQ1XA_MzNflAtpDM9pD8y97mJCXGyU2uFLy9odtY7deNaKw32kNMCGPBqVef0oY4KyIoHfUvSPL7p12cV7YuHNAKTQ3T_6H9E_JLY6oacjxPCN7_eU6PkfU07sXxcB_AVjTAPU priority: 102 providerName: Directory of Open Access Journals |
Title | Dubbing language-therapy CINEma-based in aphasia post-stroke (DULCINEA): A feasibility randomized crossover controlled trial |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39421311 https://www.proquest.com/docview/3117998844 https://pubmed.ncbi.nlm.nih.gov/PMC11483829 https://doaj.org/article/ce2c0c08ab834517a38e3fa2df23c78a |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLa2ISFeEPd1g8pIPABS1sSX2Oat6zoNRKsJUalvka9bxZpUbfowxI_HdpJpBZ54dWzFyTnW-c7tMwDvKM-0RSZE7iVOiCXEnzlGEieIFMoQYXnod55M84sZ-TKn8z2Qd70wsWhfq8VJebM8KRfXsbZytdSDrk5scDkZBQyPORKDfbDvNfSejx4jKwwzD3raFGZgV0Ippcg77N5ahct1s2zHCEWu_n8BzD_rJO8ZnvMn4HGLGOGw2dlTsGfLZ-DhpM2JPwe_zrbKu7dXsAs9Jk1P1S0cfZ6OlzIJhsrARQnl6jr0TMJVtamTTb2uflj4_mz2NcwbfvgEh9BZ2ZbL3kJvxEy1XPz0a-NXhFpP2Fa23_jBeN_HCzA7H38fXSTtnQqJxoTXiVYyY4qq3J9zFMi9uNGpUpkzTmhFpbCGGM6E87DJkFQqoaXGliBlKaac4ZfgoKxKewggYcx5E8hNTiUxViostPbutuNO2xxnPfCx-8nFqqHOKLKWXfwvifTAaRDD3cTAeh0HqvVV0cq-8FqlU51yqTgmNGMSc4udRMYhrBmXPfC2E2LhT0lIfcjSVttNgSPzHeeE9MCrRqh3r8KCoCxuge-Ie2cvu0-8YkYm7k4Rj_5_6TF4hDxOaqI6r8FBvd7aNx7n1KrvlXvO-uDB6Xh6-a0fowX9qOq_AdBmAtQ |
link.rule.ids | 230,315,730,783,787,867,888,2109,27936,27937,31732,33757,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELZKkYAL70d4GokDIG2y60dscwtpqxSSiEMjelv52UZtdqNkc2jFj8f27lZN4QJXP7TenZmd8fibzwB8oDzTFpmQuZc4IZYQb3OMJE4QKZQhwvJQ7zyZ9kcz8u2YHu-AflsLE0H7Ws27xfmiW8xPI7ZyudC9FifW-zEZhhgecyR6t8Btb7ApubZLj7kVhpkPe5pDzMCvhFJKkd-ye38VrtfNsi03FNn6_xZi3kRKXnM9Bw_Az3bRNeLkrLupVFdf3uBz_Pe3egjuN9EoHNT9j8COLR6DO5PmvP0J-LW3UX7rfALbtGZS12tdwOHhdH8hk-AEDZwXUC5PQz0mXJbrKllXq_LMwo97s3EYN_j0BQ6gs7KB4l5A7yBNuZhf-rnx-wQcKWxQ8-e-Md4l8hTMDvaPhqOkua8h0ZjwKtFKZkxR1ff_EBSIw7jRqVKZM05oRaWwhhjOhPMhmSGpVEJLjS1BylJMOcPPwG5RFvYFgIQx590rN30qibFSYaG138o77rTt46wDPrfiy5c1LUeeNczlf8i6A74GAV8NDIzasaFcneSNBHKvsTrVKZeKY0IzJjG32ElkHMKacdkB71v1yL0FhmMVWdhys85xZNXjnJAOeF6ry9WjsCAoi0vgW4q0tZbtHq8ekeW7VYeX_z_1Hbg7OpqM8_Hh9PsrcA_5eKzOHr0Gu9VqY9_4eKpSb6Px_AZtPSGJ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Lb9MwGLdgSBMX3ozyNBIHQEqbxHZicyvtqg3WagcqTeIQ-blVW5OoTQ-b-OOxHWdaB6ddHVtx_H1fvod__hmAT4QmUqfKVe45irDG2NpcjiPDMGdCYaapO-88nWUHc_zjhJwEVOU6wCpLKRb98mLZLxdnHltZL-Wgw4kNjqcjF8MjmrJBrczgPnhgjTbObmTqvr6So9yGPmEj03EspTEhqU3brc9yV-wmyZYr8oz9_wszb6Mlb7ifyWPwu5t4izo5728a0ZdXtzgd7_ZlT8CjEJXCYdvnKbiny2dgdxr23Z-DP-ONsCn0KezKm1F7busSjg5n-0seOWeo4KKEvD5z5zJhXa2baN2sqnMNP4_nR67f8Ms3OIRG8wDJvYTWUapqubiyY_0aOTwpDOj5C9vo7xR5AeaT_V-jgyjc2xBJhGkTScGTXBCR2X9J6gjEqJKxEIlRhklBONMKK5ozY0MzhWMumOQSaZwKTRChOXoJdsqq1K8AxHlurJulKiMcK80FYlLalN5QI3WGkh742omwqFt6jiIJDOb_yLsHvjshX3d0zNq-oVqdFkEKhdVcGcuYckERJknOEdXI8FSZFMmc8h742KlIYS3Rba_wUlebdYE8ux6lGPfAXqsy169CDKeJnwLdUqatuWw_sSri2b47lXh996EfwO7xeFIcHc5-vgEPUxuWtUWkt2CnWW30OxtWNeK9t5-_bxIkCQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dubbing+language-therapy+CINEma-based+in+aphasia+post-stroke+%28DULCINEA%29%3A+A+feasibility+randomized+crossover+controlled+trial&rft.jtitle=Digital+health&rft.au=Fuentes%2C+Blanca&rft.au=Jordi-Perea%2C+Pablo&rft.au=Sempere-Iborra%2C+Cristian&rft.au=Tarifa-Rodr%C3%ADguez%2C+Aida&rft.date=2024-01-01&rft.issn=2055-2076&rft.eissn=2055-2076&rft.volume=10&rft_id=info:doi/10.1177%2F20552076241288311&rft.externalDBID=n%2Fa&rft.externalDocID=10_1177_20552076241288311 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2055-2076&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2055-2076&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2055-2076&client=summon |